1. Home
  2. ALMS vs VHI Comparison

ALMS vs VHI Comparison

Compare ALMS & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • VHI
  • Stock Information
  • Founded
  • ALMS 2021
  • VHI 1932
  • Country
  • ALMS United States
  • VHI United States
  • Employees
  • ALMS N/A
  • VHI N/A
  • Industry
  • ALMS
  • VHI Major Chemicals
  • Sector
  • ALMS
  • VHI Industrials
  • Exchange
  • ALMS NYSE
  • VHI Nasdaq
  • Market Cap
  • ALMS 402.6M
  • VHI 447.6M
  • IPO Year
  • ALMS 2024
  • VHI N/A
  • Fundamental
  • Price
  • ALMS $2.86
  • VHI $15.73
  • Analyst Decision
  • ALMS Strong Buy
  • VHI Sell
  • Analyst Count
  • ALMS 7
  • VHI 1
  • Target Price
  • ALMS $24.50
  • VHI $12.00
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • VHI 16.0K
  • Earning Date
  • ALMS 08-12-2025
  • VHI 08-07-2025
  • Dividend Yield
  • ALMS N/A
  • VHI 2.05%
  • EPS Growth
  • ALMS N/A
  • VHI 4465.30
  • EPS
  • ALMS N/A
  • VHI 4.11
  • Revenue
  • ALMS $17,389,000.00
  • VHI $2,112,800,000.00
  • Revenue This Year
  • ALMS N/A
  • VHI $22.20
  • Revenue Next Year
  • ALMS N/A
  • VHI $7.66
  • P/E Ratio
  • ALMS N/A
  • VHI $3.80
  • Revenue Growth
  • ALMS N/A
  • VHI 7.82
  • 52 Week Low
  • ALMS $2.81
  • VHI $14.10
  • 52 Week High
  • ALMS $13.53
  • VHI $41.75
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • VHI 49.40
  • Support Level
  • ALMS N/A
  • VHI $15.26
  • Resistance Level
  • ALMS N/A
  • VHI $15.85
  • Average True Range (ATR)
  • ALMS 0.00
  • VHI 0.59
  • MACD
  • ALMS 0.00
  • VHI 0.10
  • Stochastic Oscillator
  • ALMS 0.00
  • VHI 57.96

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

Share on Social Networks: